Literature DB >> 626928

NMR in cancer. XI. Application of the NMR malignancy index to human gastro-intestinal tumors.

M Goldsmith, J Koutcher, R Damadian.   

Abstract

One hundred two specimens of human gastro-intestinal tissue taken from eighty-seven individuals were inspected by proton magnetic resonance techniques (at 22.5 Megahertz). The purpose of the study was to evaluate the diagnostic capabilities of the nuclear magnetic resonance (NMR) technique with regard to the diagnosis of malignancy. The combination of two NMR parameters (spin-lattice ((T1) and spin-spin ((T2)) relaxation times) into a malignancy index yielded complete discrimination between the two populations of tissue. The mean and standard deviations obtained were 2.004 +/- 0.342 for normal tissue, and 3.266 +/- 0.642 for malignant specimens. In addition, the NMR technique indicated that histologically normal tissue taken adjacent to the malignancy was pathologically "involved". Analysis of the electrolyte and water content of such tissues confirms this abnormality.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 626928     DOI: 10.1002/1097-0142(197801)41:1<183::aid-cncr2820410127>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Magnetic resonance imaging of rectal carcinoma.

Authors:  H Butler; P J Bryan
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

2.  Assessment of the pathological grade of astrocytic gliomas using an MRI score.

Authors:  S Asari; T Makabe; S Katayama; T Itoh; S Tsuchida; T Ohmoto
Journal:  Neuroradiology       Date:  1994-05       Impact factor: 2.804

3.  Changes in NMR relaxation times of adjacent muscle after implantation of malignant and normal tissue.

Authors:  C R Ling; M A Foster; J R Mallard
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

4.  NMR in cancer, XIII: application of the NMR malignancy index to human mammary tumours.

Authors:  M Goldsmith; J A Koutcher; R Damadian
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.